To investigate the mechanism of kinetic action and substrate recognition of varicella-zoster virus (VZV) thymidine kinase (TK), we designed and isolated a site-directed mutant VZV TK which has double amino acid substitutions, 136threonine to leucine and 137isoleucine to leucine (SDM TK). This mutant was designed to alter the substrate-binding site of the VZV TK to duplicate that of the herpes simplex virus type 2 enzyme. Kinetic studies of the activity of wild-type TK indicated that the binding order of ATP and thymidine is random and that wild-type VZV TK possessed high thymidylate kinase (TM-K) activity. The sensitivity of VZV TK to bisubstrate analogues, dinucleotides of adenosine and thymidine, showed that the optimum distance between the ATP- and substrate-binding sites is two phosphoryl groups greater than with the natural substrate for TK activity. SDM TK lost deoxycytidine kinase activity and had reduced TK and TM-K activities. Inhibition studies on both WT and SDM TK by 5-halogenovinyluridine analogues and their 5′ monophosphate derivatives revealed that amino acids at positions 136 and 137 are involved in substrate binding, probably through a role in the formation of the binding pocket for bulky substrates.
AyisiN. K.,
WallR. A.,
WanklinR. J.,
MachidaH.,
De ClercqE.,
SacksS. L.1987; Comparative metabolism of E-5-(2-bromovinyl)-2′-deoxyuridine and l-β-d-arabinofuranosyl-E-5-(2-bromovinyl)uracil in herpes simplex virus-infected cells. Molecular Pharmacology 31:422–429
BalasubramaniamN. K.,
VeerisettyV.,
GentryG. A.1990; Herpesviral deoxythymidine kinases contain a site analogous to the phosphoryl-binding arginine-rich region of porcine adenylate kinase; comparison of secondary structure predictions and conservation. Journal of General Virology 71:2979–2987
ChenM. S.,
PrusoffW. H.1978; Association of thymidylate kinase activity with pyrimidine deoxyribonucleoside kinase induced by herpes simplex virus. Journal of Biological Chemistry 253:1325–1327
ChenM. S.,
WalkerJ.,
PrusoffW. H.1979; Kinetic studies of herpes simplex virus type 1-encoded thymidine and thymidylate kinase, a multifunctional enzyme. Journal of Biological Chemistry 254:10747–10753
ChenM. S.,
AmicoL. A.,
SpeelmanD. J.1984; Kinetics of the interaction of monophosphates of the antiviral nucleosides 2′-fluoro-1-β-d-arabinofuranosylpyrimidine and (E)-5-(2-bromovinyl)-2′-deoxyuridine with thymidylate kinases from Vero cells and herpes simplex virus types 1 and 2. Antimicrobial Agents and Chemotherapy 26:778–780
ChengY.-C.,
TsouT. Y.,
HackstadtT.,
Malla viaL. P.1979; Induction of thymidine kinase and DNase in varicella-zoster virus-infected cells and kinetic properties of the virus-induced thymidine kinase. Journal of Virology 31:172–177
ChengY.-C.,
DutschmanG.,
De ClercqE.,
JonesA. S.,
RahimS. G.,
VerhelstG.,
WalkerR. T.1981; Differential affinities of 5-(2-halogenovinyl)-2′-deoxyuridines for deoxythymidine kinases of various origins. Molecular Pharmacology 20:230–233
DarbyG.,
LarderB. A.,
InglisM. M.1986; Evidence that the ‘active centre’ of the herpes simplex virus thymidine kinase involves an interaction between three distinct regions of the polypeptide. Journal of General Virology 67:753–758
DaviesL. C.,
StockJ. A.,
BarrieS. E.,
OrrR. M.,
HarrapK. R.1988; Dinucleotide analogues as inhibitors of thymidine kinase, thymidylate kinase, and ribonucleotide reductase. Journal of Medical Chemistry 31:1305–1308
FyfeJ. A.1982; Differential phosphorylation of (E)-5-(2-bromovinyl)-2′-deoxyuridine monophosphate by thymidylate kinases from herpes simplex viruses types 1 and 2 and varicella zoster virus. Molecular Pharmacology 21:432–437
FyfeJ. A.,
KellerP. M.,
FurmanP. A.,
MillerR. L.,
ElionG. B.1978; Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)-guanine. Journal of Biological Chemistry 253:8721–8727
GentryG. A.,
AllenG. P.,
HoltonR.,
NevinsR. B.,
McGowanJ. J.,
VeerisettyV.1983; Thymine salvage, mitochondria, and the evolution of the herpesviruses. Intervirology 19:67–76
HarrisonP. T.,
ThompsonR.,
DavisonA. J.1991; Evolution of herpesvirus thymidine kinases from cellular deoxycytidine kinase. Journal of General Virology 72:2583–2586
HayJ.,
PereraP. A. J.,
MorrisonJ. M.,
GentryG. A.,
Subak-SharpeJ. H.1971; Herpesvirus-specified proteins. In Strategy of the Viral Genome (Ciba Foundation Symposium pp. 355–376 Edited by
WolstenholmeG. E. W.,
O’ConnorM.
Edinburgh: Churchill Livingstone;
HonessR. W.,
CraxtonM. A.,
WilliamsL.,
GompelsU. A.1989; A comparative analysis of the sequence of the thymidine kinase gene of a gammaherpesvirus, herpesvirus saimirl. Journal of General Virology 70:3003–3013
KarlstromA. R.,
GronowitzJ. S.1987; An optimized thymidylate kinase assay, based on enzymatically synthesized 5-[125I]iododeoxyuridine monophosphate and its application to an immunological study of herpes simplex virus thymidine-thymidylate kinases. Analytical Biochemistry 162:500–510
LaceyS. F.,
SuzutaniT.,
PowellK. L.,
PurifoyD. J. M.,
HonessR. W.1991; Analysis of mutations in the thymidine kinase genes of drug-resistant varicella-zoster virus populations using the polymerase chain reaction. Journal of General Virology 72:623–630
RobertsonG. R.,
WhalleyJ. M.1988; Evolution of the herpes thymidine kinase: identification and comparison of the equine herpesvirus 1 thymidine kinase gene reveals similarity to a cell-encoded thymidylate kinase. Nucleic Acids Research 16:11303–11317
ShirakiK.,
OginoT.,
YamanishiK.,
TakahashiM.1985; Immunochemical characterization of pyrimidine kinase induced by varicella-zoster virus. Journal of General Virology 66:221–229
SuzutaniT.,
MachidaH.,
SakumaT.1988a; Efficacies of antiherpesvirus nucleosides against two strains of herpes simplex virus type 1 in Vero and human embryo lung fibroblast cells. Antimicrobial Agents and Chemotherapy 32:1046–1052
SuzutaniT.,
MachidaH.,
SakumaT.,
AzumaM.1988b; Effects of various nucleosides on antiviral activity and metabolism of 1 -β-d-arabinofuranosyl-E-5-(2-bromovinyl)uracil against herpes simplex virus types 1 and 2. Antimicrobial Agents and Chemotherapy 32:1547–1551
SuzutaniT.,
LaceyS. F.,
PowellK. L.,
PurifoyD. J. M.,
HonessR. W.1992; Random mutagenesis of the thymidine kinase gene of varicella-zoster virus. Journal of Virology 66:2118–2124
TaborS.,
RichardsonC. C.1985; A bacteriophage T7 RNA polymerase/promoter system for controlled exclusive expression of specific genes. Proceedings of the National Academy of Sciences, V.S.A 82:1074–1078
VeerisettyV.,
BalasubramaniamN. K.,
GentryG. A.1990; Equine herpes virus 1 and pseudorabies virus resistance to 2′-fluoropyrimidine analogs and to bromovinyldeoxyuridine: implications for dTMP kinase activity. Acta virologica 34:568–573